- •Some patients report new or worsening acne after starting elexacaftor/tezacaftor/ivacaftor.
- •The immunologic basis of this adverse effect is unclear.
- •Treatment may require trial and error with combination topical therapies or systemic therapies.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Background and epidemiology.Pediatr Clin N Am. 2016; 63 (Aug): 567-584https://doi.org/10.1016/j.pcl.2016.04.001
- Cutaneous manifestations of cystic fibrosis.Pediatr Dermatol. 2008; 25: 150-157
- Skin findings in cystic fibrosis cases.Cyprus J Med Sci. 2018; 3: 149-153
- Drug-induced acne.Clin Dermatol. 2017; 35: 156-162
- Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.N Engl J Med. 2010; 363: 1991-2003
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.Lancet N Am Ed. 2019; 394: 1940-1948
- Elexacaftor–Tezacaftor–Ivacaftor for cystic fibrosis with a single Phe508del allele.N Engl J Med. 2019; 381: 1809-1819
- Novel reaction to new cystic fibrosis medication Trikafta.Clin Case Rep. 2021; 9 (May 4): e04116
- ‘Triple therapy’ (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis.Postgrad Med J. 2022; 98 (doi: 0.1136/postgradmedj-2020-139264): 86
- CFTR modulator drug desensitization: preserving the hope of long term improvement.Pediatr Pulmonol. 2021; 56 (Aug): 2546-2552
- Rechallenge of elexacaftor/tezacaftor/ivacaftor after skin rash in two pediatric patients.J Pediatr Pharmacol Ther. 2022; 27: 463-466https://doi.org/10.5863/1551-6776-27.5.463
- A case of Elexacaftor-Tezacaftor-Ivacaftor induced rash resolving without interruption of treatment.J Cyst Fibros. 2022; S1569-1993 (Jul 1200598-7)https://doi.org/10.1016/j.jcf.2022.06.011
Witworth, J. “Dealing with Trikafta acne”. Cystic-Fibrosis.Com. 4 March 2021, cystic-fibrosis.com/living/trikafta-acne. Accessed 2 August 2022.
r/CysticFibrosis “Acne /trikafta” redditt. reddit.com/r/CysticFibrosis/comments/elz95o/acne_trikafta/. Accessed 2 August 2022.
Livingston, Jenny. “Real talk tuesday: trikafta acne”. Instagram. 23 June 2020, .instagram.com/p/CBylHiQjoUj/?hl=en. Accessed 2 August 2022.
- Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature.Dermatol Online J. 2016; 22 (1613030/qt0793n5z2)
- Treatment of acne with oral isotretinoin in patients with cystic fibrosis.Arch Dis Child. 2009; 94 (Aug): 583-586https://doi.org/10.1136/adc.2008.156406
- American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management.J Am Acad Dermatol. 2007; 56 (Apr): 651-663https://doi.org/10.1016/j.jaad.2006.08.048
- A restructuring of microbiome niche space is associated with Elexacaftor–Tezacaftor–Ivacaftor therapy in the cystic fibrosis lung.J Cyst Fibros. 2021; S1569-1993: 02131-02137https://doi.org/10.1016/j.jcf.2021.11.003
- Master in Philosophy thesis. https://livrepository.liverpool.ac.uk/3004710/1/200646917_May2016.pdf. Accessed 2 September 2022.